Ascendis Pharma AS (ASND)
128.45
+5.81
(+4.74%)
USD |
NASDAQ |
Nov 22, 13:10
Ascendis Pharma Debt to Equity Ratio: -8.104 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.104 |
| June 30, 2024 | -2.095 |
| March 31, 2024 | -2.809 |
| December 31, 2023 | -3.744 |
| September 30, 2023 | -7.644 |
| June 30, 2023 | 7.803 |
| March 31, 2023 | 3.023 |
| December 31, 2022 | 1.516 |
| September 30, 2022 | 1.225 |
| June 30, 2022 | 0.8427 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.1188 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-8.104
Minimum
Sep 2024
7.803
Maximum
Jun 2023
-0.4934
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Novo Nordisk AS | 0.4727 |
| Evaxion Biotech AS | 0.00 |
| Trinity Biotech PLC | -3.106 |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.222B |
| Total Liabilities (Quarterly) | 1.330B |
| Shareholders Equity (Quarterly) | -108.70M |
| Current Ratio | 1.161 |
| Net Debt Paydown Yield | -0.74% |